Wordt geladen...
Current treatment algorithm for the management of patients with myelofibrosis, JAK inhibitors, and beyond
Myelofibrosis (MF) is a heterogeneous disorder characterized by splenomegaly, constitutional symptoms, ineffective hematopoiesis, and an inherent risk of leukemic transformation. The past decade has seen a massive shift in available therapeutic options for our patients and we are learning how and wh...
Bewaard in:
| Gepubliceerd in: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142531/ https://ncbi.nlm.nih.gov/pubmed/29222297 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|